Barclays Maintains Overweight on Sempra, Lowers Price Target to $76
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Eric Beaumont has maintained an Overweight rating on Sempra (NYSE:SRE) but lowered the price target from $78 to $76.
October 24, 2023 | 1:56 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Sempra's price target has been lowered from $78 to $76 by Barclays, though the Overweight rating is maintained.
The news is directly about Sempra (SRE). The lowering of the price target might have a negative impact on the stock price in the short term. However, the maintained Overweight rating indicates that the analyst still sees the stock as a good investment, which could balance out the negative impact.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100